Mirum Pharmaceuticals, Inc. reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported revenue was USD 3.14 million. Net income was USD 57.55 million compared to net loss of USD 37.2 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.49 USD | +1.96% | +3.90% | -17.04% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.04% | 1.13B | |
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- MIRM Stock
- News Mirum Pharmaceuticals, Inc.
- Mirum Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021